综述
Bridging radiotherapy for chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma: Systematic review and meta-analysis
Eric Lam, Mai‐Yee Luk, Kwok-Keung Yuen, Ben Man Fei Cheung
Queen Mary Hospital
来源Radiotherapy and Oncology
年份2025
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
320
326
关键指标
3
被引次数 · OpenAlex
0.59
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 38%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
35
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学CAR-T cell therapy research
Lymphoma Diagnosis and Treatment · Immunotherapy and Immune Responses
参考文献 35
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
被引 6,114Sattva Swarup Neelapu, Frederick Lundry Locke, Nancy L. Bartlett · New England Journal of Medicine · 2017
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
被引 4,172Stephen J. Schuster, Michael Russell Bishop, Constantine Si Lun Tam · New England Journal of Medicine · 2018
The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden
被引 333Bianca Santomasso, Carlos R. Bachier, Jason R. Westin · American Society of Clinical Oncology Educational Book · 2019
此处列出前 3 条
引用本文 3
Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach
被引 5Pierre Loap, Clémentine Sarkozy, R. Dendale · Critical Reviews in Oncology/Hematology · 2026
Radiotherapy in Combination with CD20×CD3 Bispecific Antibodies for B-Cell Lymphoma: Biological Rationale, Current Evidence, and Open Questions
被引 0Patrizia Ciammella, Alberto Bavieri, Maria Elena Nizzoli · Cancers · 2026
Optimizing CAR-T therapy in diffuse large B-cell lymphoma: Biological determinants and translational strategies across the therapeutic continuum
被引 0Wang Y, Yongxian Hu · Critical Reviews in Oncology/Hematology · 2026
按被引量排序，此处列出前 3 条